Search
Akari Therapeutics PLC
AKTXAdd to Watchlist
9.160USD
-0.715-7.24%
Close 09-18 16:00（ET）
651.85MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-7.24%
5 Days
-18.94%
1 Month
+17.59%
6 Months
+76.15%
Year to Date
-20.76%
1 Year
-71.80%
Key Figures
9.630Open
10.125High
21.18KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.03%Turnover Ratio
9.875Prev. Close
9.160Low
204.59KTurnover
LossP/E Static
35.05P/B
0.00%Div Yield TTM
-66.11%ROA
29.32052wk High
0.28Volume Ratio
-19.79MNet Profit
70.02MShares
-15.4400EPS TTM
1.47Beta
-155.28%ROE
4.80052wk Low
7.59%Amplitude
--Gross Margin
651.85MMarket Cap
-2.67Reward/Risk
263.50%Risk Rate
Analyst Rating
Akari Therapeutics PLC Technical Analysis
Technical Indicators
Strong sell
Summary
Sell
Moving Average
Strong sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-2.40/-1.28
Revenue / Forecast
--/0.00
Akari Therapeutics PLC Profile
SectorPharmaceuticals
Ticker SymbolAKTX
Number of employees8
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Huh (Hoyoung) | 10.26% |
| Patel (Samir Rashmikant) | 6.93% |
| Prudo-Chlebosz (Raymond) | 6.56% |
| Armistice Capital LLC | 5.95% |
| Shareholder Types | Proportion |
|---|---|
| Individual Investor | 24.55% |
| Hedge Fund | 6.27% |
| Investment Advisor/Hedge Fund | 1.80% |
| Family Office | 0.65% |
Related Instruments
+0.04%
-0.09%
-0.04%
-0.02%
-0.19%
-0.39%
+1.55%
-0.52%
+0.07%
+0.12%
+0.35%
-1.55%
-1.65%
-1.53%
-0.56%
-0.58%
-0.55%
-2.55%
-0.73%
-0.42%
FAQs
What is the current price of Akari Therapeutics PLC (AKTX)?
The current price of Akari Therapeutics PLC (AKTX) is 9.16.
What is the symbol of Akari Therapeutics PLC?
The ticker symbol of Akari Therapeutics PLC is AKTX.
What is the 52-week high of Akari Therapeutics PLC?
The 52-week high of Akari Therapeutics PLC is 29.32.
What is the 52-week low of Akari Therapeutics PLC?
The 52-week low of Akari Therapeutics PLC is 4.80.
What is the market capitalization of Akari Therapeutics PLC?
The market capitalization of Akari Therapeutics PLC is 651.85M.
Is Akari Therapeutics PLC (AKTX) currently rated as Buy, Hold, or Sell?
According to analysts, Akari Therapeutics PLC (AKTX) has an overall rating of Buy, with a price target of 29.12.
What is the Earnings Per Share (EPS TTM) of Akari Therapeutics PLC (AKTX)?
The Earnings Per Share (EPS TTM) of Akari Therapeutics PLC (AKTX) is -15.44.